NDLI: The dynamic relationship between current and previous severe hypoglycemic events: a lagged dependent variable analysis among patients with type 2 diabetes who have initiated basal insulin.

Please wait, while we are loading the content...

Osteoporotic fractures and associated hospitalizations among patients treated with teriparatide compared to a matched cohort of patients not treated with teriparatide.

Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis.

The efficacy and safety of canagliflozin across racial groups in patients with type 2 diabetes mellitus.

Occurrence of adverse events among patients with inflammatory bowel disease in the HealthCore Integrated Research Database.

Healthcare utilization and costs among women diagnosed with uterine fibroids: a longitudinal evaluation for 5 years pre- and post-diagnosis.

Using remote ischemic conditioning to reduce acute kidney injury in patients undergoing percutaneous coronary intervention: a meta-analysis.

Historical cohort analysis of treatment patterns for patients with type 2 diabetes initiating metformin monotherapy.

Dire need of changes in the methods for assessing university faculty productivity in developing countries.

A holistic approach to chronic pain management that involves all stakeholders: change is needed.

The effect of chronic prostatitis on zinc concentration of prostatic fluid and seminal plasma: a systematic review and meta-analysis.

'Dos and don'ts' in the management of hyponatremia.

Japan Fracture Observational Study (JFOS): patient characteristics and interim data on the use of daily teriparatide in Japanese patients with osteoporosis.

Ambrisentan for the treatment of adults with pulmonary arterial hypertension: a review.

The dynamic relationship between current and previous severe hypoglycemic events: a lagged dependent variable analysis among patients with type 2 diabetes who have initiated basal insulin.

Tamsulosin combined with solifenacin versus tamsulosin monotherapy for male lower urinary tract symptoms: a meta-analysis.

Sodium glucose co-transporter inhibitors for the management of diabetes mellitus: an opinion paper from the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy.

Year: 2015 Volume: 31 Issue: 8

Year: 2015 Volume: 31 Issue: 7

Year: 2015 Volume: 31 Issue: 6

Year: 2015 Volume: 31 Issue: 5

Year: 2015 Volume: 31 Issue: 4

Year: 2015 Volume: 31 Issue: 3

Year: 2015 Volume: 31 Issue: 2

Year: 2015 Volume: 31 Issue: Supplementary 2

Year: 2015 Volume: 31 Issue: 1

Year: 2015 Volume: 31 Issue: Supplementary 1

Year: 2014 Volume: 30

Year: 2013 Volume: 29

Year: 2012 Volume: 28

Year: 2011 Volume: 27

Year: 2010 Volume: 26

Year: 2009 Volume: 25

Year: 2008 Volume: 24

Year: 2007 Volume: 23

Year: 2006 Volume: 22

Year: 1983 Volume: 8

The dynamic relationship between current and previous severe hypoglycemic events: a lagged dependent variable analysis among patients with type 2 diabetes who have initiated basal insulin.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Ganz, Michael L. Li, Qian Wintfeld, Neil S. Lee, Yuan-Chi Sorli, Christopher Huang, Joanna C.
Spatial Coverage	United States
Description	Country affiliation: United States Author Affiliation: Ganz ML ( a a Evidera , Lexington , MA , USA.); Li Q ( a a Evidera , Lexington , MA , USA.); Wintfeld NS ( b b Novo Nordisk Inc. , Plainsboro , NJ , USA.); Lee YC ( c c LA Care Health Plan , Los Angeles , CA , USA.); Sorli C ( d d Billings Clinic Research Center , Billings , MT , USA.); Huang JC ( b b Novo Nordisk Inc. , Plainsboro , NJ , USA.)
Abstract	BACKGROUND AND OBJECTIVE: Past studies have found episodes of severe hypoglycemia (SH) to be serially dependent. Those studies, however, only considered the impact of a single (index) event on future risk; few have analyzed SH risk as it evolves over time in the presence (or absence) of continuing events. The objective of this study was to determine the dynamic risks of SH events conditional on preceding SH events among patients with type 2 diabetes (T2D) who have initiated basal insulin. METHODS: We used an electronic health records database from the United States that included encounter and laboratory data and clinical notes on T2D patients who initiated basal insulin therapy between 2008 and 2011 and to identify SH events. We used a repeated-measures lagged dependent variable logistic regression model to estimate the impact of SH in one quarter on the risk of SH in the next quarter. RESULTS: We identified 7235 patients with T2D who initiated basal insulin. Patients who experienced ≥1 SH event during any quarter were more likely to have ≥1 SH event during the subsequent quarter than those who did not (predicted probabilities of 7.4% and 1.0%, respectively; p < 0.01). This effect was stronger than the impact of history of SH before starting basal insulin (predicted probabilities of 1.0% and 3.2%, respectively; p < 0.01) or of a history of SH during the titration period (predicted probabilities of 1.1% and 2.8%, respectively; p < 0.01). CONCLUSIONS: The risk of experiencing a SH event is highly dependent on a patient's immediate history of SH events and therefore the value of preventing one SH event may be substantial. These results can inform patient care by providing clinicians with dynamic data on a patient's risk of SH, which in turn can facilitate appropriate adjustment of the risk-benefit ratio for individualized patient care. These results should, however, be interpreted in light of the key limitations of our study: not all SH events may have been captured or coded in the database, data on filled prescriptions were not available, we were unable to adjust for basal insulin dose, and the post-titration follow-up period could have divided into time units other than quarters (3 month blocks) resulting in potentially different conclusions. Further real-world studies on how to best to identify patients at risk for SH events based on the presence of recent SH events, rather than on more distant 'prior' events, can help healthcare providers to better manage patients starting basal insulin.
File Format	HTM / HTML
ISSN	03007995
Issue Number	9
Volume Number	31
e-ISSN	14734877
Journal	Current Medical Research and Opinion
Language	English
Publisher	Taylor & Francis
Publisher Date	2015-01-01
Publisher Place	Great Britain (UK)
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Discipline Medicine Diabetes Mellitus, Type 2 Drug Therapy Hypoglycemia Insulin Adult Aged Databases, Factual Female Humans Chemically Induced Diagnosis Epidemiology Prevention & Control Hypoglycemic Agents Administration & Dosage Adverse Effects Logistic Models Male Middle Aged Odds Ratio Recurrence Risk Assessment Severity Of Illness Index United States Journal Article Research Support, Non-u.s. Gov't
Content Type	Text
Resource Type	Article
Subject	Medicine

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Severe hypoglycemia rates and associated costs among type 2 diabetics starting basal insulin therapy in the United States.

Increased Risk of Severe Hypoglycemic Events with Increasing Frequency of Non-severe Hypoglycemic Events in Patients with Type 1 and Type 2 Diabetes

Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis.

Insulin therapy and hypoglycemia.

Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis.

Basal insulin glargine vs prandial insulin lispro in type 2 diabetes. (Part 3)

Clinical and Economic Outcomes Associated With the Timing of Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus Previously Treated With Oral Antidiabetes Drugs.

Does diabetes have a protective effect on migraine?

Factors associated with early relapse to insulin dependence in unprovoked A-ß+ ketosis-prone diabetes.

The dynamic relationship between current and previous severe hypoglycemic events: a lagged dependent variable analysis among patients with type 2 diabetes who have initiated basal insulin.

Similar Documents

Severe hypoglycemia rates and associated costs among type 2 diabetics starting basal insulin therapy in the United States.

Increased Risk of Severe Hypoglycemic Events with Increasing Frequency of Non-severe Hypoglycemic Events in Patients with Type 1 and Type 2 Diabetes

Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis.

Insulin therapy and hypoglycemia.

Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis.

Basal insulin glargine vs prandial insulin lispro in type 2 diabetes. (Part 3)

Clinical and Economic Outcomes Associated With the Timing of Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus Previously Treated With Oral Antidiabetes Drugs.

Does diabetes have a protective effect on migraine?

Factors associated with early relapse to insulin dependence in unprovoked A-ß+ ketosis-prone diabetes.

The dynamic relationship between current and previous severe hypoglycemic events: a lagged dependent variable analysis among patients with type 2 diabetes who have initiated basal insulin.